Back to DE D. E. Shaw & Co., Inc.
CUE4 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in CUE BIOPHARMA INC
No. D. E. Shaw exited its CUE (Cue Biopharma) position in Q3 2023. Its Q2 2023 13F listed 36,681 shares worth $133,886. D. E. Shaw first reported CUE in Q4 2019 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$205,000
Total Shares Change
-12,908
Quarter-by-Quarter History
Other major holders of CUE: Avoro Capital Advisors LLC, STATE STREET CORP